Menu
Search
|

Menu

Close
X

BioTelemetry Inc BEAT.OQ (NASDAQ Stock Exchange Global Select Market)

67.87 USD
-- (--)
As of Mar 20
chart
Previous Close 67.87
Open --
Volume --
3m Avg Volume 224,285
Today’s High --
Today’s Low --
52 Week High 80.80
52 Week Low 29.95
Shares Outstanding (mil) 33.61
Market Capitalization (mil) 2,280.96
Forward P/E 56.84
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.67 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY18
399
FY17
287
FY16
208
EPS (USD)
FY18
1.194
FY17
-0.245
FY16
1.700
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
56.84
58.80
Price to Sales (TTM)
vs sector
5.71
8.99
Price to Book (MRQ)
vs sector
7.30
4.66
Price to Cash Flow (TTM)
vs sector
27.80
40.60
Total Debt to Equity (MRQ)
vs sector
64.52
17.49
LT Debt to Equity (MRQ)
vs sector
62.34
13.83
Return on Investment (TTM)
vs sector
8.28
12.11
Return on Equity (TTM)
vs sector
15.26
13.22

EXECUTIVE LEADERSHIP

Kirk Gorman
Independent Chairman of the Board, Since 2011
Salary: --
Bonus: --
Joseph Capper
President, Chief Executive Officer, Director, Since 2010
Salary: $577,089.00
Bonus: --
Heather Getz
Chief Financial Officer, Executive Vice President, Since 2017
Salary: $371,101.00
Bonus: --
Fred Broadway
President, BioTel Heart, Since 2018
Salary: $301,981.00
Bonus: --
Peter Ferola
Senior Vice President,General Counsel and Secretary, Since 2012
Salary: $323,821.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Healthcare Facilities & Services
Address:

1000 Cedar Hollow Rd
MALVERN   PA   19355-2300

Phone: +1610.7297000

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates in three segments: Healthcare, Technology and Research. The Healthcare segment, operating as CardioNet, LLC and Heartcare Corporation of America, Inc., is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Research segment, operating as Cardiocore, LLC and VirtualScopics, Inc., is engaged in laboratory services that provide cardiac monitoring, imaging services, scientific consulting and data management services for drug, medical treatment and device trials. The Technology segment, operating as Braemar Manufacturing, LLC, Universal Medical, Inc. and BioTelemetry Belgium BVBA. and BioTelemetry Technology ApS, focuses on the manufacturing, engineering and development of noninvasive cardiac monitors for healthcare companies.

SPONSORED STORIES